A Phase I Study With SJG-136 (NSC #694501) in Patients With an Advanced Solid Tumor

Trial Profile

A Phase I Study With SJG-136 (NSC #694501) in Patients With an Advanced Solid Tumor

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Dec 2013

At a glance

  • Drugs SG 2000 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 17 Jul 2007 Status changed from suspended to completed.
    • 07 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top